MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12967-026-08505-3

Медицинская библиотека · Journal of translational medicine · 2026

Identification of a 10-protein plasma signature for preclinical gout risk beyond serum urate: a robustness-first proteomic study in 33,147 normouricaemic individuals.

Yuan Yue, Zhang Huan, Zhang Kun, Wang Mingzhu, Yan Hao, Zhang Junyang, Wen Chengping, Guo Zheshan, Huang Lin, Wang Zhaoxiang

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Gout risk assessment is currently reactive, relying on hyperuricaemia. However, a significant clinical gap exists for individuals who develop gout despite maintaining "normal" serum urate levels. We aimed to identify a plasma proteomic signature that defines a susceptibility state for gout years before clinical onset, specifically within individuals who are normouricaemic at baseline.

METHODS

We analyzed large-scale plasma proteomic data (2,920 proteins) from 33,147 normouricaemic individuals (baseline serum urate < 360 μmol/L) in the UK Biobank. To ensure findings were not artifacts of specific algorithms, we employed a "robustness-first" machine-learning framework encompassing 756 model configurations. Longitudinal protein trajectories were traced up to 15 years prior to diagnosis. Incident osteoarthritis was used as a negative control to evaluate specificity.

RESULTS

A 10-protein signature (including VSIG4, UBQLN3, and MB) predicted incident gout with high discrimination (ROC-AUC = 0.892). This signature identified a high-risk subgroup with a 4.46-fold increased hazard, independent of baseline serum urate and conventional risk factors. Notably, protein trajectories diverged between future cases and controls 10-15 years before clinical diagnosis, even while serum urate remained within the normal range. The signature showed minimal discrimination for osteoarthritis (AUC ≈ 0.60).

CONCLUSIONS

In 33,147 normouricaemic individuals, plasma proteomics identifies a stable preclinical susceptibility state for gout that exists beyond the traditional serum urate paradigm. This 10-protein signature enables early risk stratification and offers a significant window for precision prevention a decade before clinical onset.

Для цитирования: Yuan Yue, Zhang Huan, Zhang Kun, Wang Mingzhu, Yan Hao, Zhang Junyang, Wen Chengping, Guo Zheshan, Huang Lin, Wang Zhaoxiang. Identification of a 10-protein plasma signature for preclinical gout risk beyond serum urate: a robustness-first proteomic study in 33,147 normouricaemic individuals.. Journal of translational medicine. 2026. DOI: 10.1186/s12967-026-08505-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.